Jun-Gyu Park

Jun-Gyu Park

Texas Biomedical Research Institute

Affiliated withTexas Biomedical Research Institute University of Rochester Medical Center

Research Area

Immunology and Infection

Biography

Jun-Gyu Park has not added Biography.
If you are Jun-Gyu Park and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 2	Year
Publication title	2019
Publication title	2021

Other Publications

Article	Year
Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus. bioRxiv : the preprint server for biology\| PubMed ID: 32511383	2020
Structural basis of RNA cap modification by SARS-CoV-2. Nature communications\| PubMed ID: 32709886	2020
Identification of Inhibitors of ZIKV Replication. Viruses\| PubMed ID: 32961956	2020
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome. mBio\| PubMed ID: 32978313	2020
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. Journal of virological methods\| PubMed ID: 33068703	2021
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nature communications\| PubMed ID: 33257679	2020
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes. Journal of virology\| PubMed ID: 33431557	2021
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants. Journal of virological methods\| PubMed ID: 33513380	2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters. Cell reports. Medicine\| PubMed ID: 33649747	2021
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 33721754	2021
FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling. bioRxiv : the preprint server for biology\| PubMed ID: 33907746	2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents. bioRxiv : the preprint server for biology\| PubMed ID: 34013274	2021
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. Journal of virology\| PubMed ID: 34133899	2021
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2. iScience\| PubMed ID: 34368648	2021
Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 34561300	2021
The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus. Journal of virology\| PubMed ID: 34668775	2021